- Home
- VKTX vs ADX Comparison
VKTX vs ADX Comparison
Compare VKTX & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | ADX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.2B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VKTX | ADX |
|---|---|---|
| Price | $30.79 | $25.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $94.82 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 226.4K |
| Earning Date | 10-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.77 | $20.91 |
| 52 Week High | $43.15 | $26.56 |
Technical Indicators
Market Signals| Indicator | VKTX | ADX |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 47.36 |
| Support Level | $29.52 | $25.72 |
| Resistance Level | $35.47 | $26.39 |
| Average True Range (ATR) | 2.30 | 0.26 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 27.41 | 50.02 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector-neutral approach. The fund has a diversified equity portfolio that consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.